U.S. Markets closed

Eli Lilly’s Q2 2018 Earnings: New Products

Mike Benson
Eli Lilly’s Q2 2018 Earnings: New Products

Eli Lilly & Co.’s (LLY) new products portfolio includes several drugs that have been launched since 2014. This portfolio includes Olumiant, Lartruvo, Taltz, Jardiance, Trulicity, Cyramza, Basaglar, and Verzenio. The chart below compares the revenues for LLY’s new products since the first quarter of 2017.